Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Johny Kharouba"'
Publikováno v:
Journal of Clinical Pediatric Dentistry. 44:60-65
Objective: Sedation using 50% nitrous oxide (N2O) concentration is common in pediatric dentistry. The aim to assess sedation and cooperation levels following sedation with 60% and 70% N2O concentrations in children whose dental treatment failed using
Autor:
Marry Nassar, Anan Safadi, Mulham Sabbah, Mostafa Somri, Alexey Khorev, Johny Kharouba, Sigalit Blumer, Yara Srour, Benjamin Peretz, Nasir Hawash
Publikováno v:
International journal of paediatric dentistry. 28(1)
Background Efficacy of pre-emptive analgesia compared to preventive regimen, managing postoperative pain is still controversial. Aim Evaluating the efficacy of intravenous (IV) paracetamol as pre-emptive analgesia compared to preventive post-treatmen
Autor:
Naomi Cherni, Johny Kharouba, L. Gaitini, Geith Darawshi, Ami Smidt, Mostafa Somri, Constantinos A. Parisinos, Zackariya Abu Ras
Publikováno v:
International Journal of Paediatric Dentistry. 22:271-279
International Journal of Paediatric Dentistry 2012; 22: 271–279 Background. Midazolam sedation poses a significant dilemma in paediatric dentistry, which is to find out the optimal dosing with minimal undesirable adverse events. In this study, we a
Publikováno v:
The Journal of clinical pediatric dentistry. 38(3)
We describe the dental findings and therapeutic management of a child aged three years and eight months with medulloblastoma treated by surgical resection at age eight months followed by 20 months of chemotherapy. Thin and short roots of the primary
Autor:
Mostafa, Somri, Constantinos A, Parisinos, Johny, Kharouba, Naomi, Cherni, Ami, Smidt, Zackariya, Abu Ras, Geith, Darawshi, Luis A, Gaitini
Publikováno v:
International journal of paediatric dentistry. 22(4)
Midazolam sedation poses a significant dilemma in paediatric dentistry, which is to find out the optimal dosing with minimal undesirable adverse events. In this study, we aimed to compare the effect of three doses of oral midazolam (0.5, 0.75, and 1